Flow Cytometric MRD Detection in Selected Mature B-Cell Malignancies
Author:
Publisher
Springer New York
Link
http://link.springer.com/content/pdf/10.1007/978-1-4939-9151-8_8
Reference87 articles.
1. Fischer K, Bahlo J, Fink AM et al (2016) Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial. Blood 127:208–215
2. Hermine O, Hoster E, Walewski J et al (2016) Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network. Lancet 388:565–575
3. European Medicines Agency Committee for Medicinal Products for Human Use (2016) Appendix 4 to the guideline on the evaluation of anticancer medicinal products in man. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2016/02/WC500201945.pdf , Accessed 15 Mar 2018
4. Fink AM, Bottcher S, Ritgen M et al (2013) Prediction of poor outcome in CLL patients following first-line treatment with fludarabine, cyclophosphamide and rituximab. Leukemia 27:1949–1952
5. Cramer P, von Tresckow J, Bahlo J et al (2018) CLL2-BXX Phase II trials: sequential, targeted treatment for eradication of minimal residual disease in chronic lymphocytic leukemia. Future Oncol (London, England) 14:499–513
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Utility of Measurable Residual Disease (MRD) Assessment in Mantle Cell Lymphoma;Current Treatment Options in Oncology;2023-05-30
2. Contemporary Challenges in Clinical Flow Cytometry: Small Samples, Big Data, Little Time;The Journal of Applied Laboratory Medicine;2022-01-21
3. Stance of MRD in Non-Hodgkin’s Lymphoma and its upsurge in the novel era of cell-free DNA;Clinical and Translational Oncology;2021-05-15
4. Exosome: From leukemia progression to a novel therapeutic approach in leukemia treatment;BioFactors;2020-08-14
5. Chronic Lymphocytic Leukemia;Cold Spring Harbor Perspectives in Medicine;2020-03-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3